Cancer has caused us to focus on all the things we have to be thankful for and to actively seek them out.
Vickie Gibson Poe
In the Genitourinary Cancer Center, you are the focus of a team of experts who specialize in kidney cancer and strive to provide the most advanced treatment with the least impact on your body.
Working together, this team of surgical and medical oncologists, as well as a specially trained support staff, utilizes the latest leading-edge technology and techniques from diagnosis through treatment. Your kidney cancer treatment options may include:
- Kidney-sparing surgery
- Laparoscopic and robotic surgery
- Targeted therapies including Sutent® (sunitinib) Nexavar® (sorafenib) Torisel® (temsirolimus) and Avastin® (bevacizumab)
- Immunotherapy, including interferon and interleukin-2
- Cryoablation, radiofrequency ablation and active surveillance
And, at MD Anderson you're surrounded by the strength of one of the nation's largest and most experienced comprehensive cancer centers, which has all the support and wellness services needed to treat the whole person – not just the disease.
While the American Urological Association estimates the average urologist sees six cancer and non-cancer kidney tumor cases a year, MD Anderson treats more than 700 kidney cancer patients annually. This gives us an extraordinary level of expertise and experience that can make a vital difference in the success of your treatment and recovery.
At MD Anderson, you benefit from one of the most active kidney cancer research programs in the United States. This means we are able to offer a wide range of clinical trials (research studies) for new treatments for most types and stages of kidney cancer.
Understanding a disease is the first step toward finding the right care. Get the facts about kidney cancer, including the different types, how it starts and who’s at risk.
Did You Know?
Treatment options are available for cancer patients dealing with sexual problems. Talk to your doctor about any concerns.
May 16, 2016
Tennessee resident Philip Prichard hadn’t even heard of immunotherapy or Nivolumab when he was first diagnosed with kidney cancer in the summer of 2012.
But it’s precisely that drug and groundbreaking type of cancer treatment that eventually saved his life.
Philip was on his way home from a business trip to South Carolina when he began feeling pain in his right side and leg. He told his wife he wasn...